This statistic shows the expenditure of pharmaceutical company Teva for research and development from 2006 to 2024. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2024, the company invested nearly one billion U.S. dollars in research and development. However, this was still significantly lower than the expenditures in 2016-2017.
Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024
(in million U.S. dollars)
Characteristic
Expenditure in million U.S. dollars
2024
998
2023
953
2022
838
2021
967
2020
997
2019
1,010
2018
1,213
2017
1,778
2016
2,077
2015
1,525
2014
1,488
2013
1,427
2012
1,356
05001,0001,5002,0002,500
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Statista has been my savior on several occasions.
The site is easy to maneuver and the data is in a format that can
go right into a report or presentation.
Learn more about how Statista can support your business.
Teva Pharmaceutical, & U.S. Securities and Exchange Commission. (February 5, 2025). Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 25, 2025, from https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/
Teva Pharmaceutical, und U.S. Securities and Exchange Commission. "Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars)." Chart. February 5, 2025. Statista. Accessed April 25, 2025. https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/
Teva Pharmaceutical, U.S. Securities and Exchange Commission. (2025). Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 25, 2025. https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/
Teva Pharmaceutical, and U.S. Securities and Exchange Commission. "Expenditure on Research and Development of Teva Pharmaceutical Industries from 2006 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 5 Feb 2025, https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/
Teva Pharmaceutical & U.S. Securities and Exchange Commission, Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/ (last visited April 25, 2025)
Expenditure on research and development of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars) [Graph], Teva Pharmaceutical, & U.S. Securities and Exchange Commission, February 5, 2025. [Online]. Available: https://www.statista.com/statistics/272544/expenditure-on-research-and-development-by-teva-since-2006/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
